Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-4090

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text consists of information about Metoprolol Succinate tablets in 25 mg strength. The tablets are in a quantity of 5 and are extended-release. The tablets are made by Oryza Pharmaceuticals Inc. and are repackaged by Remedy Repack Inc. Directions for use can be found in the package insert, and it is recommended to store the tablets at a temperature between 20-25°C, protecting them from moisture and out of reach from children.*

FDA Label Image

Figure (Figure001)

This text provides information on the efficacy of Wetoprolol Succinate Extended-Release Tablets in reducing total mortality and hospitalizations due to heart failure. The results from the MERIT-HF study are presented for various subgroups based on factors such as ejection fraction, ethnicity, previous medical history (such as MI, diabetes, and hypertension), and heart rate. The data includes relative risk values and 95% confidence intervals. Overall, this text offers valuable insights into the impact of Wetoprolol Succinate in heart failure management.*

FDA Label Image

Structure (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.